Portola Pharmaceuticals Inc (PTLA) - Financial and Strategic SWOT Analysis Review

  • ID: 4278641
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 5


  • Galena Biopharma Inc
  • KemPharm Inc
  • Xencor Inc
  • MORE

Portola Pharmaceuticals Inc (Portola Pharmaceuticals) is a biopharmaceutical company which conducts research to develop therapeutics in the areas of thrombosis, other hematologic disorders and inflammation. The company's products portfolio include Betrixaban, an oral once-daily Factor Xa inhibitor anticoagulant that inhibits the activity of Factor Xa; andexanet alfa, a recombinant protein designed to reverse anticoagulant activity of both direct and indirect Factor Xa inhibitors; and cerdulatinib, an oral, dual Syk-JAK inhibitor in development to treat hematologic cancers. Portola Pharmaceuticals provides compounds using biomarker and genetic approaches for clinical, regulatory and commercial purpose of life-saving therapies . The company works in collaboration with other pharmaceutical and biotechnology companies for the clinical development of its lead candidates. Portola Pharmaceuticals is headquartered in South San Francisco, California, the US.

Portola Pharmaceuticals Inc Key Recent Developments

Feb 28, 2018: Portola Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
Dec 22, 2017: Portola Pharmaceuticals to Webcast Corporate Update on January 9, 2018
Nov 06, 2017: Portola Pharmaceuticals Appoints Industry Veteran John H. Lawrence, M.D., as Senior Vice President and Chief Medical Officer
Nov 06, 2017: Portola Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Corporate Update
Aug 09, 2017: Portola Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate Update

This comprehensive SWOT profile of Portola Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Portola Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 5


  • Galena Biopharma Inc
  • KemPharm Inc
  • Xencor Inc
  • MORE
Section 1 - About the Company
  • Portola Pharmaceuticals Inc - Key Information
  • Portola Pharmaceuticals Inc - Overview
  • Portola Pharmaceuticals Inc - Key Employees
  • Portola Pharmaceuticals Inc - Key Employee Biographies
  • Portola Pharmaceuticals Inc - Key Operational Heads
  • Portola Pharmaceuticals Inc - Major Products and Services
  • Portola Pharmaceuticals Inc - History
  • Portola Pharmaceuticals Inc - Company Statement
  • Portola Pharmaceuticals Inc - Locations And Subsidiaries
  • Portola Pharmaceuticals Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Portola Pharmaceuticals Inc - Business Description
  • Portola Pharmaceuticals Inc - Corporate Strategy
  • Portola Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Portola Pharmaceuticals Inc - Strengths
  • Portola Pharmaceuticals Inc - Weaknesses
  • Portola Pharmaceuticals Inc - Opportunities
  • Portola Pharmaceuticals Inc - Threats
  • Portola Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Portola Pharmaceuticals Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Portola Pharmaceuticals Inc, Key Information
  • Portola Pharmaceuticals Inc, Key Ratios
  • Portola Pharmaceuticals Inc, Share Data
  • Portola Pharmaceuticals Inc, Major Products and Services
  • Portola Pharmaceuticals Inc, History
  • Portola Pharmaceuticals Inc, Key Employees
  • Portola Pharmaceuticals Inc, Key Employee Biographies
  • Portola Pharmaceuticals Inc, Key Operational Heads
  • Portola Pharmaceuticals Inc, Other Locations
  • Portola Pharmaceuticals Inc, Subsidiaries
  • Portola Pharmaceuticals Inc, Key Manufacturing facilities
  • Portola Pharmaceuticals Inc, Key Competitors
  • Portola Pharmaceuticals Inc, SWOT Analysis
  • Portola Pharmaceuticals Inc, Ratios based on current share price
  • Portola Pharmaceuticals Inc, Annual Ratios
  • Portola Pharmaceuticals Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Portola Pharmaceuticals Inc, Performance Chart
  • Portola Pharmaceuticals Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • Xencor Inc
  • KemPharm Inc
  • Inotek Pharmaceuticals Corp
  • Galena Biopharma Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown